期刊文献+

EPO联合谷氨酰胺对坏死性小肠结肠炎早产儿胃肠道激素、粪便细菌指标和血清i-FABP、TNF-α、IL-6水平的影响 被引量:7

Effects of EPO Combined with Glutamine on Gastrointestinal Hormones,Fecal Bacteria and Serum i-FABP,TNF-α,IL-6 Levels in Premature Infants with Necrotizing Enterocolitis
原文传递
导出
摘要 目的:探讨促红细胞生成素(EPO)联合谷氨酰胺对坏死性小肠结肠炎(NEC)早产儿胃肠道激素、粪便细菌指标和血清肿瘤坏死因子(TNF-α)、白细胞介素-6(IL-6)、肠脂肪酸结合蛋白(i-FABP)水平的影响。方法:选取2016年12月~2019年12月期间山东大学附属山东省妇幼保健院及徐州医科大学附属医院NICU收治的NEC早产儿120例,根据随机数字表法将患儿分为E-PO组(EPO治疗)、谷氨酰胺组(谷氨酰胺治疗)、联合组(EPO联合谷氨酰胺治疗),每组各40例。对比三组患儿疗效、胃肠道激素、粪便细菌指标和血清i-FABP、TNF-α、IL-6水平,记录三组不良反应发生率和病死率。结果:联合组的临床总有效率高于谷氨酰胺组、EPO组(P<0.05)。三组治疗后血清TNF-α、IL-6、i-FABP水平均较治疗前下降,且联合组低于谷氨酰胺组、EPO组(P<0.05)。三组治疗后胃泌素(MTL)和胃动素(GAS)水平均较治疗前升高,且联合组高于谷氨酰胺组、EPO组(P<0.05)。三组治疗后细菌总数、杆菌总数、球菌总数均较治疗前升高,且联合组高于谷氨酰胺组、EPO组(P<0.05)。联合组不良反应发生率、病死率均低于谷氨酰胺组、EPO组(P<0.05)。结论:EPO联合谷氨酰胺治疗NEC早产儿,可有效改善胃肠道功能,调节肠道菌群,改善血清炎症因子及i-FABP水平,减少不良反应发生率、病死率,疗效显著。 Objective:To investigate the effects of erythropoietin(EPO)combined with glutamine on gastrointestinal hormones,fecal bacteria and serum tumor necrosis factor-α(TNF-α),interleukin-6(IL-6)and intestinal fatty acid binding protein(i-FABP)levels in premature infants with necrotizing enterocolitis(NEC).Methods:120 cases of NEC premature infants in Shandong Maternal and Child Health Hospital Affiliated to Shandong University and Affiliated Hospital of Xuzhou Medical University from December 2016 to December 2019 were selected,and they were randomly divided into EPO group(EPO treatment),glutamine group(glutamine treatment)and combination group(EPO combined with glutamine treatment),40 cases in each group.The curative effect,gastrointestinal hormones,fecal bacterial indicators and serum i-FABP,TNF-α,IL-6 levels of the three groups were compared,and the incidence rate of adverse reactions and mortality of the three groups were recorded.Results:The total effective rate of the combination group was higher than that of the glutamine group and EPO group(P<0.05).After treatment,the TNF-α,IL-6 and i-FABP levels in the three groups were lower than those before treatment,and those in the combination group were lower than those in the glutamine group and EPO group(P<0.05).After treatment,the gastrin(MTL)and motilin(GAS)levels in the three groups were higher than those before treatment,and those in the combination group were higher than those in the glutamine group and EPO group(P<0.05).After treatment,the total number of bacteria,bacilli and cocci in the three groups were higher than those before treatment,and those in the combination group were higher than those in the glutamine group and EPO group(P<0.05).The incidence rate of adverse reactions and mortality in combination group were lower than those in glutamine group and EPO group(P<0.05).Conclusion:EPO combined with glutamine in the treatment of NEC premature infants can effectively improve gastrointestinal function,regulate intestinal flora,improve serum inflammatory factors and i-FABP levels,reduce the incidence of adverse reactions and case fatality,with a significant efficacy.
作者 张恩胜 王静 陈前 王军 黄磊 ZHANG En-sheng;WANG Jing;CHEN Qian;WANG Jun;HUANG Lei(Department of Pediatrics,Shandong Maternal and Child Health Hospital,Jin'an,Shandong,250014,China;Department of Urology Surgery,The First Affiliated Hospital of Shandong First Medical University,Jin'an,Shandong,250014,China;Department of Neonatology,Affiliated Hospital of Xuzhou Medical University,Xuzhou,Jiangsu,221002,China)
出处 《现代生物医学进展》 CAS 2021年第15期2973-2977,共5页 Progress in Modern Biomedicine
基金 山东省医药卫生科技发展计划面上项目(2016WS0375)。
关键词 促红细胞生成素 谷氨酰胺 坏死性小肠结肠炎 早产儿 胃肠道激素 粪便细菌 TNF-α IL-6 i-FABP Erythropoietin Glutamine Necrotizing enterocolitis Premature infants Gastrointestinal hormones Fecal bacteria TNF-α IL-6 i-FABP
  • 相关文献

参考文献11

二级参考文献89

  • 1贾盛华,韦红,余加林,魏小娣,张晓萍,李金纯.姜黄素对新生大鼠坏死性小肠结肠炎的保护作用[J].中国当代儿科杂志,2010,12(2):132-136. 被引量:14
  • 2徐德斌,钱桂生,侯一峰,赵晓利,陈维中,李淑萍.噬菌体展示短肽模拟脂多糖结合蛋白抗炎功能位点的研究[J].第三军医大学学报,2004,26(7):573-575. 被引量:6
  • 3黄谱,苟文丽.未足月胎膜早破的促胎肺成熟治疗[J].中国实用妇科与产科杂志,2006,22(6):409-411. 被引量:52
  • 4李正红,王丹华,董梅.谷氨酰胺在早产儿肠外营养中的应用研究[J].中国新生儿科杂志,2006,21(3):139-142. 被引量:14
  • 5Henry MC, Moss RI. Necrotizing enterocolitis. Annu Rev Med, 2009,60 : 111-124.
  • 6Morowitz MJ, Poroyko V, Caplan M, et al. Redefining the role of in-testinal microbes in the pathogenesis of necrotizing enterocolitis. Pediatrics ,2010,125 (4) :777-785.
  • 7Kao NR, Xenocostas A, Driman DK, et al. Recombinant human erythropoietin improves gut barrier function in a hemorrhagic shock and resuscitation rat model. J Trauma, 2011,71 (5 suppl 1 ) : S456- 461.
  • 8Zanjani ED, Pixley JS, Slotnik N, et al. Erythropoietin does not cross the placenta into the fetus. Pathobiology, 1993,61 (3-4) :211-215.
  • 9Dame C, Fahnenstich H, Freitag P, et al. Erythropoietin mRNA ex- pression in human fetal and neonatal tissue. Blood, 1998,92 (9) : 3218-3225.
  • 10Claud EC. Neonatal necrotizing enterocolitis-inflammation and intes- tinal immaturity. Antiinflamm Antiallergy Agents Med Chem,2009, 8 (3) :248-259.

共引文献127

同被引文献98

引证文献7

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部